ADVERTISEMENT
search.svg

 

Press Releases

 

APhA Statement Following Emergency Use Authorization of the Moderna COVID-19 Vaccine

WASHINGTON, DC -- Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists Association, upon the Food and Drug Administration’s (FDA) decision to authorize emergency use of Moderna’s COVID-19 vaccine:

“With the FDA’s action today, pharmacists are again prepared to step forward and serve as essential health care providers in the historic effort to control and end this pandemic.

Pharmacy Organizations Welcome FDA Authorization of COVID Vaccine: “We Stand Ready to Serve”

WASHINGTON, D.C. -- The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration’s approval of the first Emergency Use Authorization for the COVID-19 vaccine. 

“We heartily welcome the decision by the U.S. Food and Drug Administration (FDA) to authorize the emergency use of the first COVID-19 vaccine, following the recommendation of the Vaccines and Related Biological Products Advisory Committee (VRBPAC). 

“This is a historic moment in the nation’s effort to end the pandemic. The pharmacy profession is ready to do its part as qualified, active participants in administering these vaccines in accordance with guidance issued by the FDA, CDC, HHS and state and local health departments, as well as increasing access for the American public to these important disease prevention tools.

American Pharmacists Association Hails Supreme Court Ruling on Pharmacy Benefit Managers

The American Pharmacists Association today hailed the unanimous decision of the U.S. Supreme Court upholding the right of Arkansas to regulate pharmacy benefit management (PBM) companies.

“This is a great day for pharmacists and their patients,” said Scott J. Knoer, executive vice president and CEO of the American Pharmacists Association. “For years, PBMs have threatened the sacrosanct relationship between pharmacists and their patients and have never been forced to answer to any authority for their actions. This opinion redresses that imbalance and returns the power to protect the interests of patients to the states and other local authorities, where it belongs.”

American Pharmacists Association Announces Recipients of 2021 Awards and Honors

The American Pharmacists Association (APhA) today announced the selection of recipients of the Professionwide Awards as part of the 2021 APhA Awards and Honors Program. 

Honorees will be officially recognized at APhA2021, which is scheduled to take place March 12–15, 2021. The APhA Awards and Honors Program is the most comprehensive recognition program in the profession of pharmacy. For more information, visit pharmacist.com/awards.

American Pharmacists Association Announces 2021 APhA Fellows

The American Pharmacists Association (APhA) today announced the selection of the APhA Fellows as part of the 2021 APhA Awards and Honors Program. 

Honorees will be officially recognized at APhA2021, which is scheduled to take place March 12–15, 2021. The APhA Awards and Honors Program is the most comprehensive recognition program in the profession of pharmacy. For more information, visit pharmacist.com/awards.

APhA Fellows are members of either the APhA Academy of Pharmacy Practice & Management (APhA–APPM) or the APhA Academy of Pharmaceutical Research & Science (APhA–APRS), with a minimum of 10 years of professional experience. To become an APhA Fellow, members must demonstrate exemplary professional achievements and service to the profession through activities with APhA and other national, state and/or local professional organizations.

The Academies have selected the following members as the 2021 APhA Fellows. Here is a glimpse of their work and accomplishments:

RSS
First567810121314